研究单位：[1]Beijing Tongren Hospital,Shanghai Huilun Pharmaceutical Co., Ltd.[2]The First Affiliated Hospital of Anhui Medical University,Hefei 1808722,Anhui 1818058,China[3]Wuhan Center Hospital,Wuhan 1791247,Hubei 1806949,China[4]Wuhan No.1 Hospital,Wuhan 1791247,Hubei 1806949,China[5]The Second Affiliated Hospital of Suzhou University,Suzhou 1886760,Jiangsu 1806260,China[6]Beijing Tongren Hospital, Capital Medical University,Beijing 1816670,China[7]Ciivil Aviation General Hospital,Beijing 1816670,China
The goal of this clinical trial is to learn if Qianweitai (QWT, silodosin capsule) works to treat BPH/LUTS in male adults. It will also learn the safety about QWT. The main questions it aims to answer are: 1. Whether QWT is non inferior to tamsulosin in the reduction of IPSS total score？ 2. Dose QWT have other advantages in the improvement of LUTS? Participants will: 1. Orally take QWT twice daily or tamsulosin once daily for 12 weeks. 2. Visit the clinic at week 1、 2、4、8 and 12 for checkups and tests.
